Pancreatic Cancer Research

ResearcherEssen University HospitalNo recent work listed

Maximilian Markus

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7449-4248; OpenAlex author ID A5087979605. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 3

  1. Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols. Co-author DOI 10.1159/000529452↗
  2. Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy. Co-author DOI 10.1007/s00432-020-03361-0↗
  3. Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols. Co-author DOI 10.1007/s00432-018-2789-z↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stefan Kasper · 3 shared papers, 2019–2023 · strength 0.32
  2. Marcel Wiesweg · 3 shared papers, 2019–2023 · strength 0.32
  3. Jens Thomas Siveke · 2 shared papers, 2021–2023 · strength 0.24
  4. Annalena Abendroth · 2 shared papers, 2019–2021 · strength 0.19
  5. Sven‐Thorsten Liffers · 1 shared paper, 2023 · strength 0.13
  6. Julius Röhrle · 1 shared paper, 2023 · strength 0.13
  7. Timm M. Reißig · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.